Results 201 to 210 of about 4,732,777 (361)
Elastography and MRI for the Evaluation of Complete Response to Neoadjuvant Therapy for Breast Cancer. [PDF]
Horvat JV, Fazzio RT.
europepmc +1 more source
ABSTRACT Background Segmental tracheal resection is rarely needed for advanced thyroid cancer but is among the most complex, high‐risk thyroid surgeries. Methods Retrospective study of patients undergoing segmental tracheal resection for thyroid cancer at MD Anderson Cancer Center (2005–2024).
Anastasios Maniakas +19 more
wiley +1 more source
Quality of life following total neoadjuvant therapy for rectal cancer. [PDF]
Wurschi GW +15 more
europepmc +1 more source
Neoadjuvant Immunotherapy for Periauricular Cutaneous Squamous Cell Carcinoma
ABSTRACT Background The standard‐of‐care for advanced periauricular cutaneous squamous cell carcinoma (pCSCC) is surgery and adjuvant radiation therapy. Neoadjuvant immunotherapy recently demonstrated high pathologic response rates in patients with resectable pCSCC.
David Z. Allen +6 more
wiley +1 more source
Neoadjuvant Radiochemotherapy and Total Neoadjuvant Therapy in the Management of Locally Advanced Rectal Cancer. [PDF]
Yigit M +6 more
europepmc +1 more source
ABSTRACT Background University of Michigan Cancer Center (UMCC) protocol 9520 treated stage III/IV locally advanced squamous cell carcinoma of the larynx (LASCCL) with cisplatin and 5‐fluorouracil to select for definitive therapy based on response.
Zachary Risch +19 more
wiley +1 more source
Editorial: The role of adjuvant and neoadjuvant therapy in resectable esophageal cancer. [PDF]
Li X, Cong Z, Qiang Y.
europepmc +1 more source
ABSTRACT Background The gingiva and floor of the mouth are distinct subsites, and oral squamous cell carcinoma (OSCC) originating in these locations warrants further indepth understanding. Methods This study enrolled patients with OSCC from 2000 to 2020, and analyzed the clinicopathological characteristics.
Hao Li +12 more
wiley +1 more source
Association of Tumor-Infiltrating Lymphocytes (TILs) With Pathological Complete Response to Neoadjuvant Therapy in Breast Cancer. [PDF]
Ul Ain N +6 more
europepmc +1 more source

